跳至主要内容
临床试验/ACTRN12620000681954
ACTRN12620000681954尚未招募未知

Harnessing new mHealth technologies to Strengthen the Management ofMultidrug-Resistant Tuberculosis in Vietnam: The V-SMART trial

niversity of Sydney0 个研究点目标入组 902 人开始时间: 2020年6月15日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
902

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 o limit(—)
性别
All

入选标准

  • Aged greater than or equal to 15 years
  • - Have a diagnosis of bacteriologically confirmed pulmonary and/or extrapulmonary rifampicin resistant (RR) or multidrug-resistant (MDR)-TB
  • - Have commenced MDR-TB treatment within the previous 30 days
  • - Demonstrate the ability to operate simple functions on a smartphone (including entering a passcode, opening an application and making a phone call)

排除标准

  • - Inability to provide written informed consent (e.g. due to a significant communication impairment)
  • - Do not intend to receive treatment within participating provinces over the subsequent 12 month period
  • - Another person residing within the same household, at least one day per week, has already been enrolled and randomized within this study.

研究者

相似试验